Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Head and Neck Neoplasms 1Enteral Feeding for Head and Neck Cancer Patients 1Breakthrough Pain 1

Interventions

Cyclophosphamide 2040Radiotherapy 1854Cisplatin 1820Carboplatin 1530Gemcitabine 1432Paclitaxel 1289Bevacizumab 1267Docetaxel 1200pembrolizumab 1196Oxaliplatin 1157Capecitabine 1140Fluorouracil 1059Dexamethasone 971Rituximab 918Nivolumab 908Magnetic Resonance Spectroscopy 858Etoposide 839Doxorubicin 823Drug Therapy 789Radiosurgery 774Irinotecan 774Cytarabine 736fludarabine 714Leucovorin 674Lenalidomide 608fludarabine phosphate 564Temozolomide 552Filgrastim 540Radiation 539Cetuximab 535

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Interventional × Gastrostomy × Clear all
NCT02869321 2019-05-13

ANTALGIP

Central Hospital, Nancy, France

Phase 4 Completed
20 enrolled
Head & Neck

Head and Neck Neoplasms, Breakthrough Pain

NCT02675673 2016-06-23

Feeding Tube in Cancer Patients

University Health Network, Toronto

Phase NA Withdrawn
Head & Neck

Enteral Feeding for Head and Neck Cancer Patients

Data powered by HemOnc (CC BY 4.0) Colophon âš¡